Skip to content

Effect of cheek Acupuncture on Perioperative Analgesia and Postoperative Recovery in Patients Undergoing Thoracoscopic Surgery

Effect of cheek Acupuncture on Perioperative Analgesia and Postoperative Recovery in Patients Undergoing Thoracoscopic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002536
Enrollment
Unknown
Registered
2025-12-24
Start date
2025-12-20
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative analgesia and postoperative rehabilitation

Interventions

Cheek Acupuncture Combined with Ropivacaine Incision Infiltration Group:After general anesthesia intubation, cheek acupuncture will be performed, and ropivacaine incision infiltration will be carried
Ropivacaine Incision Infiltration Group:No acupuncture treatment will be given. Ropivacaine incision infiltration will be performed before incision suturing.
Paravertebral Block Group:Paravertebral nerve block will be performed after general anesthesia and intubation.

Sponsors

155 Nanjing North Street, Heping District, Shenyang City, Liaoning Province, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients scheduled for thoracoscopic surgery under general anesthesia; (2) Age ranging from 18 to 70 years at the time of enrollment; (3) American Society of Anaesthesiologists (ASA) physical status class I to III; (4) 18kg/m ^ 2 = body mass index (BMI) = 24kg/m ^ 2; (5) Surgical time less than 5 hours; (6) Unilateral surgery; (7) Thoroughly understand the experiment and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients who refuse to participate in the study; (2) Patients with abnormal coagulation function; (3) Patients with infected or ruptured skin at the acupuncture points; (4) Patients with a history of chronic pain (lasting for more than 3 months) or continuous use of analgesics within 2 weeks before surgery; (5) Patients with drug abuse or alcohol dependence; (6) Patients with a history of severe liver, kidney or heart abnormalities within the past six months; (7) Patients with severe visual or auditory deficiencies; (8) Patients with consciousness disorders or mental or neurological diseases and unable to cooperate; (9) Patients who have undergone thoracotomy in the past; (10) Patients with lung diseases such as pulmonary infections and asthma. (11) Patients who convert to thoracotomy or be transferred to the intensive care unit after surgery;

Design outcomes

Primary

MeasureTime frame
Total opioid consumption within the first 24 postoperative hours;

Secondary

MeasureTime frame
Time to first rescue opioid administration;Number of rescue opioid administrations within 24 hours;Pain at rest (numerical rating scale);Movement-evoked pain (numerical rating scale);Pain Score at 3 Months Postoperatively;Ramsay Sedation Scale;Opioid-related adverse events;Procedure-related complications;Awakening due to pain (Yes/No);Ambulate independently (Yes/No);Passing flatus (Yes/No);Length of stay;

Countries

China

Contacts

Public ContactBao Naren

First Affiliated Hospital of China Medical University

bnrlzh@sina.com+86 138 4202 1591

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026